Literature DB >> 21931059

Dramatic improvement of facial angiofibromas in tuberous sclerosis with topical rapamycin: optimizing a treatment protocol.

Cynthia M C DeKlotz, Alicia E Ogram, Saurabh Singh, Sridhar Dronavalli, Jennifer L MacGregor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21931059     DOI： 10.1001/archdermatol.2011.254

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  14 in total

1.  Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas.

Authors:  Guillaume Le Guyader; Victoire Vieillard; Karine Andrieux; Mylène Rollo; Olivier Thirion; Pierre Wolkenstein; Muriel Paul
Journal:  Eur J Hosp Pharm       Date:  2018-11-10

2.  Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial.

Authors:  Mari Wataya-Kaneda; Yuuki Ohno; Yasuyuki Fujita; Hiroo Yokozeki; Hironori Niizeki; Masaaki Ogai; Kazuyoshi Fukai; Hiroshi Nagai; Yuichi Yoshida; Izumi Hamada; Taihei Hio; Kenji Shimizu; Hiroyuki Murota
Journal:  JAMA Dermatol       Date:  2018-07-01       Impact factor: 10.282

3.  Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial.

Authors:  Mary Kay Koenig; Cynthia S Bell; Adelaide A Hebert; Joan Roberson; Joshua A Samuels; John M Slopis; Patti Tate; Hope Northrup
Journal:  JAMA Dermatol       Date:  2018-07-01       Impact factor: 10.282

Review 4.  Targeted treatment trials for tuberous sclerosis and autism: no longer a dream.

Authors:  Mustafa Sahin
Journal:  Curr Opin Neurobiol       Date:  2012-05-04       Impact factor: 6.627

5.  Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin.

Authors:  Mary Kay Koenig; Adelaide A Hebert; Joan Roberson; Joshua Samuels; John Slopis; Audrey Woerner; Hope Northrup
Journal:  Drugs R D       Date:  2012-09-01

6.  Topical rapamycin (sirolimus) for facial angiofibromas.

Authors:  Bhushan Madke
Journal:  Indian Dermatol Online J       Date:  2013-01

7.  Challenges in the management of a case of tuberous sclerosis.

Authors:  Anubhav Rathi; Manjeet Singh Bhatia; Anurag Jhanjee
Journal:  Ind Psychiatry J       Date:  2012-07

8.  Do you know this syndrome?

Authors:  Gabriela Maria Abreu Gontijo
Journal:  An Bras Dermatol       Date:  2013 Mar-Apr       Impact factor: 1.896

Review 9.  Is mTOR inhibition a systemic treatment for tuberous sclerosis?

Authors:  Romina Moavero; Antonella Coniglio; Francesco Garaci; Paolo Curatolo
Journal:  Ital J Pediatr       Date:  2013-09-17       Impact factor: 2.638

10.  Topical rapamycin as a treatment for fibrofolliculomas in Birt-Hogg-Dubé syndrome: a double-blind placebo-controlled randomized split-face trial.

Authors:  Lieke M C Gijezen; Marigje Vernooij; Herm Martens; Charlene E U Oduber; Charles J M Henquet; Theo M Starink; Martin H Prins; Fred H Menko; Patty J Nelemans; Maurice A M van Steensel
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.